2014-10-14T09:05:04-05:00 2014-05-31 410746749 CLIFTONLARSONALLEN LLP 220 SOUTH SIXTH STREET SUITE 300 MINNEAPOLIS MN 55402 990 2013-06-01 410693869 INNOVATIVE BLOOD RESOURCES INNO 6513327000 737 PELHAM BOULEVARD ST PAUL MN 551141739 JOHN M BUSKE VP OF FINANCE & BUS ALLIANCES 6513327000 2014-10-09 1 JOHN TAUER P00294068 6123764500 2013 2015-11-30 17:44:51Z DONALD C BERGLUND 737 PELHAM BOULEVARD ST PAUL MN 551141739 66238805 0 X WWW.MBC.ORG X 1947 MN SUPPLY BLOOD AND BLOOD COMPONENTS TO 50 HOSPITALS IN MINNESOTA, WISCONSIN AND NEBRASKA. 12 12 541 96000 0 0 432545 9394038 50182656 53006759 32448 91919 342349 460187 50989998 62952903 0 0 0 0 21847904 24941502 0 0 219295 28295170 28650524 50143074 53592026 846924 9360877 31173738 43183688 8536052 8558165 22637686 34625523 X SAVING LIVES BY PROVIDING BLOOD AND BIOMEDICAL SOLUTIONS. 0 1 45611564 0 53006759 INNOVATIVE BLOOD RESOURCES IS A NONPROFIT COMMUNITY BLOOD CENTER THAT SERVES AS THE MAJOR SUPPLIER OF BLOOD AND BLOOD COMPONENTS TO 50 HOSPITALS IN THE TWIN CITIES METRO AREA, NORTHERN MINNESOTA, NORTHWESTERN WISCONSIN, AND NEBRASKA. INNOVATIVE BLOOD RESOURCES IS A LEADER IN TRANSFUSION MEDICINE, PROVIDING EXPERT TECHNICAL SERVICES TO CLIENTS THROUGHOUT THE COUNTRY. AMONG THE SERVICES INNOVATIVE BLOOD RESOURCES PROVIDES ARE CONSULTING, REFERENCE LABORATORY WORK, VIROLOGY TESTING, RESEARCH, AND ORGAN AND MARROW TRANSPLANTATION SUPPORT. 45611564 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 34 0 541 1 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MN WI X JOHN M BUSKE VP OF FINANCE AND BU 6513327000 737 PELHAM BOULEVARD ST PAUL MN 551141739 THOMAS F HEANEY CHAIRMAN 1.00 X X 0 0 0 ANDREW J DETLEFSEN VICE CHAIR 1.00 X X 0 0 0 THOMAS E BECKER MD SECRETARY 1.00 X X 0 0 0 SCOTT BECKER DIRECTOR 1.00 X 0 0 0 PATRICK COURNEYA MD DIRECTOR 1.00 X 0 0 0 MATTHEW DOKKEN DIRECTOR 1.00 X 0 0 0 JAMES DOWIAK DIRECTOR 1.00 X 0 0 0 TIMOTHY KUCK DIRECTOR 1.00 X 0 0 0 DEREK LESTER MD DIRECTOR 1.00 X 0 0 0 SCOTT LYNCH DIRECTOR 1.00 X 0 0 0 PHILLIP MARTIN DIRECTOR 1.00 X 0 0 0 ART MOLNAR MD DIRECTOR 1.00 X 0 0 0 DONALD C BERGLUND CEO 40.00 X 339512 0 29685 PHYLLIS A ERICSON COO 40.00 X 223903 0 4157 JOHN M BUSKE VP OF FINANCE & BUSINESS ALLIANCES 40.00 X 191035 0 8954 JED B GORLIN MD VP OF MED & QUALITY AFFAIR 40.00 X 321868 0 33990 JUDITH PETERSEN VP OF CLIENT SERVICES 40.00 X 159675 0 23653 ELIZABETH H PERRY MD ASSOC. MEDICAL DIRECTOR 40.00 X 196974 0 25951 KRISTINE A BELANGER VP OF DONOR SERVICES 40.00 X 125755 0 6043 WENDY L CAPETZ DIR. OF MARKETING & DEVELOPMENT 40.00 X 115609 0 4500 MARK A JANZEN VP OF LABORATORY SERVICES 40.00 X 111722 0 24056 KENNETH P KIEFFER VP OF RECRUITMENT, COLLECTIONS 40.00 X 129209 0 6128 1915262 0 167117 12 0 1 0 MCGOUGH FACILITY MANAGEMENT 2737 FAIRVIEW AVENUE NORTH ST PAUL MN 55113 FACILITIES MANAGEMENT 781282 FEDERAL EXPRESS CORPORATION PO BOX 94515 PALATINE IL 600944515 COURIER SERVICES 462931 HYBRID COURIER 29870 HAILEYS COURT CEDAR MN 55013 COURIER SERVICES 227592 MIDNIGHT EXPRESS 26305 NETWORK PLACE CHICAGO IL 606731260 COURIER SERVICES 196674 LABORATORY CORPORATION OF AMERICA PO BOX 12140 BURLINGTON NC 272162140 TESTING SERVICES 136340 9 74052 9319986 9005973 9394038 SERVICE FEE - UNIT 621500 40002025 40002025 LABORATORY SERVICES 621500 9576869 9576869 PLASMA AND ANTISERUM 621500 2915625 2915625 RESEARCH PROJECTS 621500 418727 418727 TRANSPORTATION 621500 73973 73973 19540 19540 53006759 21610 21610 3246317 3173053 2955 73264 -2955 70309 70309 37883 74052 109894 -72011 -72011 MISCELLANEOUS 900099 532198 532198 532198 62952903 53006759 0 552106 1369843 422382 947461 18106563 15328629 2617154 160780 405520 335539 68244 1737 3757399 2877939 864044 15416 1302177 1053233 243818 5126 41964 41964 114892 114892 60466 60466 798308 338408 459900 203906 250 190888 12768 2113671 1821544 291731 396 576698 483272 93426 1815111 1246268 567087 1756 763197 658691 103318 1188 152506 575 145559 6372 217022 183623 31099 2300 2654457 2457139 192493 4825 258114 126291 131823 REAGENTS 9890405 9890405 MEDICAL SUPPLIES 6870103 6863891 6212 EQUIP RENTAL/MAINT 867788 772931 94857 DONOR & EMPL RECOGNITIO 795773 686496 109217 60 456143 64058 385514 6571 53592026 45611564 7761167 219295 3656816 7704161 7195975 7084592 1293600 1365033 303612 410278 32755973 14793738 11488064 17962235 6935671 7463922 300000 1085431 0 107952 0 84 31173738 43183688 4871764 5434028 88715 13800 2784399 2435841 559214 526183 175327 103362 56633 44951 8536052 8558165 X 22574134 34510729 63552 114794 22637686 34625523 31173738 43183688 X 9360877 1875 2625085 X 0 1 X 1 0 X 465428 462287 512135 432545 9394038 11266433 48520947 47857318 51648585 50235525 53044642 251307017 48986375 48319605 52160720 50668070 62438680 262573450 11839 13570 12445 8337 4278 50469 24382504 25028021 27789998 27803853 24954937 129959313 24394343 25041591 27802443 27812190 24959215 130009782 132563668 3124 12692 21959 28567 21610 87952 3124 12692 21959 28567 21610 87952 630054 765888 486745 417017 532198 2831902 49619553 49098185 52669424 51113654 62992488 265493304 0.49930 0.47170 0.00030 0.00040 X SCHEDULE A, PART II, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2009 AMOUNT: $ 630,054. 2010 AMOUNT: $ 765,888. 2011 AMOUNT: $ 486,745. 2012 AMOUNT: $ 417,017. 2013 AMOUNT: $ 532,198. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2435630 2435630 16319273 5175086 11144187 1899668 1618774 280894 11649039 7999878 3649161 452363 452363 17962235 ASSET RETIREMENT OBLIGATION 44951 44951 X PART X, LINE 2: INNOVATIVE BLOOD RESOURCES IS A NONPROFIT ORGANIZATION AND EXEMPT, AS A PUBLIC CHARITY, FROM TAXATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND APPLICABLE STATE STATUTES. INNOVATIVE BLOOD RESOURCES FOLLOWS THE ACCOUNTING STANDARDS FOR CONTINGENCIES IN EVALUATING UNCERTAIN TAX POSITIONS. THIS GUIDANCE PRESCRIBES RECOGNITION THRESHOLD PRINCIPLES FOR THE FINANCIAL STATEMENT RECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN ON A TAX RETURN THAT ARE NOT CERTAIN TO BE REALIZED. INNOVATIVE BLOOD RESOURCES' TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL AND STATE AUTHORITIES. THE TAX RETURNS FOR THE YEARS 2011 THROUGH 2013 ARE OPEN TO EXAMINATION BY FEDERAL AND STATE AUTHORITIES. WHAT'S YOUR TYPE METRO 111935 74052 37883 36232 2380 20493 9860 40929 111935 74052 37883 36232 2380 20493 9860 40929 109894 -72011 X X X X X X 0 1 0 0 0 0 0 0 0 DONALD C BERGLUND CEO 296083 0 32819 0 10610 0 10000 0 19685 0 369197 0 0 0 PHYLLIS A ERICSON COO 16790 0 0 0 207113 0 2183 0 1974 0 228060 0 0 0 JOHN M BUSKE VP OF FINANCE & BUSINESS ALLIANCES 178563 0 9955 0 2517 0 7275 0 1679 0 199989 0 0 0 JED B GORLIN MD VP OF MED & QUALITY AFFAIR 285816 0 16200 0 19852 0 10000 0 23990 0 355858 0 0 0 JUDITH PETERSEN VP OF CLIENT SERVICES 150149 0 7500 0 2026 0 6263 0 17390 0 183328 0 0 0 ELIZABETH H PERRY MD ASSOC. MEDICAL DIRECTOR 188441 0 6950 0 1583 0 4544 0 21407 0 222925 0 0 0 PART I, LINE 4B INNOVATIVE BLOOD RESOURCES HAS IN PLACE A 457(F) PLAN WHICH DOES COVER VARIOUS INDIVIDUALS OF MANAGEMENT. IN 2013, INVOLVEMENT IN THE PLAN OCCURED AS FOLLOWS: NAME CONTRIBUTIONS WITHDRAWALS DONALD C. BERGLUND $66,216 $ 0 JOHN M. BUSKE $32,184 $ 0 ROVENA L. CLAXTON $10,670 $13,473 JED B. GORLIN, MD $43,210 $44,827 JUDITH A. PETERSON $13,600 $ 7,497 A PORT AUTHORITY OF THE CITY OF ST PAUL MN 416005524 584991AC7 2005-11-08 4500000 BUILDING ACQUISITION & RENOVATION 737 PELHAM BLVD, ST. PAUL, MN 0 0 0 A 2064071 4500000 30000 4500000 2005 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 0 A 0 0 1 0 0 0 0 0 0 A 0 X FMV OF NEBRAS 1 8966400 X SPECIAL EVENT 148 39573 0 1 0 PART I, COLUMN (B): PART I, COLUMN B IS EQUAL TO ESTIMATED TOTAL NUMBER OF CONTRIBUTORS FORM 990, PART III, LINE 3 EFFECTIVE DECEMBER 31, 2013, INNOVATIVE BLOOD RESOURCES AGREED TO SELL IT'S PARENTAGE LINE OF OPERATIONS. FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIR, VICE CHAIR, SECRETARY, TREASURER AND OTHER DIRECTOR(S) DESIGNATED BY THE BOARD OF DIRECTORS TO SERVE ON THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE HAS THE AUTHORITY OF THE BOARD OF DIRECTORS IN THE MANAGEMENT OF THE BUSINESS OF THE ORGANIZATION BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, MONITORS THE ACTIVITIES OF THE STANDING COMMITTEES OF THE CORPORATION AND ASSISTS IN IMPROVING PROCESSES WHERE APPROPRIATE, AND AT ALL TIMES IS SUBJECT TO THE CONTROL AND DIRECTION OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WILL BE REVIEWED AND APPROVED BY THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS. ONCE APPROVED BY THE FINANCE COMMITTEE, THE FORM 990 IS SHARED WITH THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C DIRECTORS AND OFFICERS MUST DISCLOSE ALL CONFLICTS OF INTEREST AND MUST ANNUALLY COMPLETE AND RETURN TO THE NOMINATING AND GOVERNANCE COMMITTEE THE QUESTIONNAIRE WHICH IS A PART OF THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. WHENEVER IN THE COURSE OF EVENTS A DIRECTOR'S OR OFFICER'S CIRCUMSTANCES CHANGE, SO THAT HE OR SHE KNOWS OR HAS REASON TO KNOW THAT AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MAY ARISE, SUCH DIRECTOR OR OFFICER SHALL PROMPTLY DISCLOSE THE POTENTIAL CONFLICT TO THE NOMINATING AND GOVERNANCE COMMITTEE. THE DIRECTOR OR OFFICER SHALL NOT PARTICIPATE IN, TAKE ANY ACTION UPON, OR VOTE UPON SUCH MATTERS UNTIL THE QUESTION OF THE EXISTENCE OF THE CONFLICT OF INTEREST HAS BEEN DETERMINED BY THE NOMINATING AND GOVERNANCE COMMITTEE. WHEN A CONFLICT OF INTEREST DOES IN FACT EXIST UNDER THE DEFINITION SET FORTH ABOVE, THE PERSON WITH THE CONFLICT OF INTEREST SHALL NOT BE COUNTED FOR DETERMINING THE PRESENCE OF A QUORUM, EVEN WHEN PERMITTED BY LAW AND SHALL NOT PARTICIPATE IN ANY WAY IN, OR BE PRESENT DURING, THE DELIBERATIONS AND DECISION-MAKING VOTE WITH RESPECT TO THE MATTER. NEVERTHELESS, THE INTERESTED PARTY SHALL HAVE AN OPPORTUNITY TO PROVIDE FACTUAL INFORMATION ABOUT THE MATTER. THE MINUTES OF THE MEETING SHOULD REFLECT THAT THE DIRECTOR OR OFFICER HAVING A CONFLICT DISCLOSED SUCH INTEREST AND ABSTAINED VOTING ON THE MATTER AND THAT A QUORUM WAS PRESENT FOR SUCH ACTION. FORM 990, PART VI, SECTION B, LINE 15 THE HUMAN RESOURCES COMMITTEE OF THE BOARD OF DIRECTORS, COMPOSED ENTIRELY OF INDEPENDENT PERSONS, OVERSEES EXECUTIVE COMPENSATION AND, IN DOING SO, RETAINS AN EXTERNAL PARTY TO CONDUCT AN INDEPENDENT MARKET SURVEY ON A REGULAR BASIS (EVERY 2 - 3 YEARS). THE PROCESS INCLUDED REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTIATION IN 2012 FOR THE CEO, D. BERGLUND; CFO, J. BUSKE; VP OF MEDICAL & QUALITY AFFAIRS, J. GORLIN; VP OF CLIENT SERVICES, J. PETERSEN; AND ASSOCIATE MEDICAL DIRECTOR, E. PERRY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY OR FINANCIAL STATEMENTS OPEN TO THE PUBLIC. FORM 990, PART XI, LINE 9: LOSS ON IMPAIRMENT OF FIXED ASSETS -738,810. INCREASE IN FMV OF FIXED ASSETS UPON AFFILIATION 3,130,346. ADJUSTMENT OF NET ASSETS UPON AFFILIATION 233,549. NATIONAL BLOOD COLLABORATIVE LLC 737 PELHAM BLVD SAINT PAUL MN 55114 455601065 COLLECTION, DISTRIBUTION & MANAGEMENT OF BLOOD PRODUCTS MN N/A RELATED -14384 13735 0 0 0.14290 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0